SINT

SiNtx Technologies Inc. Common Stock (SINT)

Stock · NASDAQ · Health Care

$1.75as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

SINTX Q3 Revenue Tops Guidance; Analyst Raises Target. SiNtx Technologies reported preliminary Q3 revenue of $2.2 million, significantly exceeding its previous guidance range of $0.9 million to $1.1 million. Following this update, Ascendiant Capital raised its price target to $12.50. This strong revenue performance stands out against the stock's 52-week range of $1.40 to $4.66.

Active signals

Support level
$1.56
Industry
Medical/Dental Instruments

What SINT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike29-10.8%31%
Bollinger Band Breakdown26-5.8%46%
Bollinger Band Breakout18-15.3%22%
200-Day Moving Average TouchActive now7+3.4%57%
Any 20-session window (baseline)-10.3%31%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SINT

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon ni…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
32
Website
sintx.com/

Fundamentals

1-day range
$1.69$1.78
Market cap
$10.36M
P/E (trailing)
—
P/E (forward)
-1.61
EPS (trailing)
$-3.03
Dividend yield
—
Beta
0.57
Avg. volume
115.8K
Dividend pay date
July 29, 2019
52-week range
$1.4$4.5

How SiNtx Technologies Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.02MSG&A$6.44M (633%)R&D$4.59M (451%)Cost of Revenue$557.0K (55%)SINT

Source: 10-K filed Mar 20, 2026 · via SEC EDGAR / Finnhub

Gross Profit$461.0K(45%)
Operating Income-$10.72M(-1053%)

Forecasts

4 analyst ratings

Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$12.5
+614.3%
Median
$9.25
+428.6%
Low
$6
+242.9%

SiNtx Technologies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • SINT
    SiNtx Technologies Inc. Common Stock
    $1.74
    ▼ 1.69%
    Market cap $10.36MP/E —
    $1.4$4.5
  • ICCM
    IceCure Medical Ltd. Ordinary Shares
    $1.06
    ▲ 1.92%
    Market cap $10.55MP/E —
    $1.04$29.46
  • CODX
    Co-Diagnostics Inc. Common Stock
    $0.654
    ▼ 8.53%
    Market cap $9.91MP/E —
    $0.746$46.5
  • MODD
    Modular Medical Inc. Common Stock
    $2.32
    ▲ 7.18%
    Market cap $10.99MP/E —
    $1.72$18.76
  • AMIX
    Autonomix Medical Inc. Common Stock
    $2.85
    ▼ 2.90%
    Market cap $11.82MP/E —
    $2.44$32.55
  • FEMY
    Femasys Inc. Common Stock
    $1.65
    ▼ 4.90%
    Market cap $8.91MP/E —
    $1.67$22.2
  • ICU
    SeaStar Medical Holding Corporation Common Stock
    $2.9
    ▼ 5.23%
    Market cap $12.19MP/E —
    $2.07$7.35

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
4.9K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
199.5K
Total value held
$496.5K
Institutional holders
20
Top holders this quarter
  • Unknown76.7K
  • Unknown32.1K
  • Unknown20.9K
  • Unknown17.0K
  • Unknown13.3K
  • Unknown12.1K
  • Unknown10.0K
  • Unknown10.0K
  • Unknown5.0K
  • Unknown1.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.